IQ GENETIC TECHNOLOGY LIMITED × HKRM Lab Joint Product

News Center

Tracking the latest research and clinical advances in stem cell exosome therapy

📊 Research News
Tsinghua Team Breakthrough: Inhaled Stem Cell Exosomes Reverse Pulmonary Fibrosis in 7 Days — 24-Patient Clinical Data Published in Nature Sub-journal

A research team led by Professor Chang Zhijie from the School of Basic Medical Sciences, Tsinghua University, in collaboration with the PLA General Hospital and other institutions, has published landmark findings in the prestigious journal Signal Transduction and Targeted Therapy (a Nature sub-journal), demonstrating that inhaled human umbilical cord mesenchymal stem cell exosomes (hUCMSC-EVs) can safely and effectively reverse pulmonary fibrosis.

🩺 Research News
Chang Zhijie Group Develops Novel Pulmonary Fibrosis Treatment and Completes Phase I Clinical Trial

The research group led by Professor Chang Zhijie at Tsinghua University School of Medicine has developed a method of treating pulmonary fibrosis through inhaled extracellular vesicles (exosomes) derived from umbilical cord mesenchymal stem cells, and has completed the world's first Phase I clinical trial in this field.

Consult